ArticleAtherosclerosis plus2026
Associations of NMR metabolic biomarkers and arterial calcification: An observational and Mendelian randomization study within the BBMRI metabolomics consortium.
Article in Atherosclerosis plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim: The metabolic roles in arterial calcification remain largely unclear. We aimed to elucidate the associations between nuclear magnetic resonance (NMR) metabolic biomarkers with site- and sex-specific arterial calcification as well as their causal nature. Methods: This study included participants from the Rotterdam Study (RS, N = 1062), Leiden Longevity Study (LLS, N = 272), and UK Biobank (UKBB, N = 271,793). In RS and LLS, we applied linear regression (both overall and sex-stratified) to assess the association between NMR metabolic biomarkers and arterial calcification at coronary artery (CAC), aortic arch (AAC), and aortic valve (AVC). Two-sample Mendelian randomization (MR) was employed using genome-wide association study of NMR biomarkers (N = 115,082) and CAC (N = 26,909) to infer their genetic causality. Biomarkers with consistent observational and causal associations were further examined for associations with coronary heart disease (CHD) in UKBB. Results: From multiple-testing correction (P-value < 4.39 × 10 Conclusions: We identified NMR-based metabolic biomarkers, particularly fatty acid ratios, that were significantly and causally associated with CAC burden. GlycA was associated with CAC in males only. Replication in UKBB further underscores their clinical relevance with CHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.